Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01335633 · ClinicalTrials.gov registry record
Psychometric Validation of Cognitive Endpoints
A clinical trial, sponsored by Kessler Foundation.
- Completed
- Registry status
- 60
- Enrollment target
NCT01335633: Completed study, sponsored by Kessler Foundation.
NCT01335633 is a clinical trial that has completed, run by Kessler Foundation. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01335633 has completed, sponsored by Kessler Foundation.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The study will entail cognitive assessment of a single cohort of patients with Multiple Sclerosis. Each subject will be assessed twice, approximately 45 days apart. There will be no intervention or control group. Each participant will have a caregiver capable of responding to a brief report of observations regarding neuropsychological skills and abilities in the patient.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-08 |
What the finished NCT01335633 record still lists
NCT01335633 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01335633 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01335633 about?
NCT01335633 is a clinical study titled "Psychometric Validation of Cognitive Endpoints". The study will entail cognitive assessment of a single cohort of patients with Multiple Sclerosis. Each subject will be assessed twice, approximately 45 days apart. There will be no intervention or control group. Each participant will have a caregiver capable of responding to a brief report of obser...
What is the current status of trial NCT01335633?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2011-03. Estimated completion is 2011-08.
Who is sponsoring clinical trial NCT01335633?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia